Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
High Risk
100%
Graft-versus-host Disease (GvHD)
100%
Disease-specific Mortality
100%
Allogeneic
100%
Stem Cell Transplant Recipients
100%
Transplant-related Mortality
100%
Peripheral Blood Stem Cell Transplantation
100%
Chronic Graft-versus-host Disease (cGVHD)
100%
Allogeneic Peripheral Blood Stem Cell Transplantation
60%
Transplantation
40%
Performance Status
20%
Hematological Malignancies
20%
Immunosuppression
20%
Granulocyte Colony-stimulating Factor (G-CSF)
20%
Survivors
20%
Corticosteroids
20%
Cyclosporine
20%
Effective Strategies
20%
Extensive Disease
20%
Day Range
20%
High-dose Therapy
20%
Long-term Survivors
20%
Progression-free
20%
Graft-versus-host Disease Prophylaxis
20%
HLA-identical Sibling
20%
First Remission
20%
First Relapse
20%
95% Confidence Interval
20%
Consecutive Patients
20%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Stem Cell Transplant
100%
Peripheral Blood Stem Cell
100%
Chronic Graft Versus Host Disease
80%
Allogeneic Peripheral Blood Stem Cell Transplantation
60%
Drug Megadose
20%
Immunosuppression
20%
Granulocyte Colony-Stimulating Factor
20%
Acute Graft Versus Host Disease
20%
Ciclosporin
20%
Progression Free Survival
20%